Get started
Author

Jean‐Philippe David

Observed names: J P David, J. P. David, J.-P David, J.-P. David, J.P. David, Jean-Philippe David, JeanPhilippe David
Observed institutions: Inserm, Université Paris-Est Créteil, Centre Hospitalier Universitaire de Lille, Centre Hospitalier Universitaire Henri-Mondor, Assistance Publique – Hôpitaux de Paris, Centre hospitalier Emile Roux, Hôpital Roger Salengro, Hôpital Émile-Roux, Pitié-Salpêtrière Hospital, Centre Hospitalier Sainte-Anne, Hôpitaux Universitaires Henri-Mondor, Institut Mondor de Recherche Biomédicale, Université Paris Descartes, Laboratoire de Psychopathologie et Processus de Santé, Pôle de recherche et d'enseignement supérieur Université Paris-Est
OpenAlex ID: A5111869481
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease
1999 · A. Delacourte, J.P. David, et al. · Neurology · 830
Neurosteroid Quantification in Human Brain Regions: Comparison between Alzheimer’s and Nondemented Patients
2002 · Sébastien Weill-Engerer, Jean-Philippe David, et al. · The Journal of Clinical Endocrinology & Metabolism · 331
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer’s disease
2002 · A. Delacourte, N. Sergeant, et al. · Neurology · 168
Glial reaction in the hippocampal formation is highly correlated with aging in human brain
1997 · Jean-Philippe David, Farida Ghozali, et al. · Neuroscience Letters · 145
Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases
1997 · N Sergeant, J.-P David, et al. · FEBS Letters · 117
Association of atp synthase α-chain with neurofibrillary degeneration in alzheimer’s disease
2003 · N Sergeant, A Wattez, et al. · Neuroscience · 103
Tau aggregation in the hippocampal formation: an ageing or a pathological process?
2002 · André Delacourte, Nicolas Sergeant, et al. · Experimental Gerontology · 97
Clinical Characteristics and Outcomes of 821 Older Patients With SARS-Cov-2 Infection Admitted to Acute Care Geriatric Wards
2020 · Lorène Zerah, Édouard Baudouin, et al. · The Journals of Gerontology Series A · 92
PDF
Quantification of Reduced and Oxidized Glutathione in Whole Blood Samples by Capillary Electrophoresis
2001 · Valérie Serru, Bruno Baudin, et al. · Clinical Chemistry · 75
Geriatric assessment findings independently associated with clinical depression in 1092 older patients with cancer: the ELCAPA Cohort Study
2015 · Florence Canoui‐Poitrine, Nicoleta Reinald, et al. · Psycho-Oncology · 71
Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP‐CTFs), associated with tau pathology stages, in Alzheimer's disease
2002 · Nicolas Sergeant, Jean‐Philippe David, et al. · Journal of Neurochemistry · 66
Interrelations between body mass index, frailty, and clinical adverse events in older community-dwelling women: The EPIDOS cohort study
2017 · Emmanuelle Boutin, Pierre-André Natella, et al. · Clinical Nutrition · 52
PDF
Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation
2020 · Olivier Hanon, Jean-Sébastien Vidal, et al. · Heart · 46
Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects
1992 · Patrick Vermersch, Bernard Frigard, et al. · Neuroscience Letters · 44
Sequence of neurofibrillary changes in aging and Alzheimer's disease: A confocal study with phospho-tau antibody, AD2
2001 · M. Galván, J.P. David, et al. · Journal of Alzheimer s Disease · 43
Several frailty parameters highly prevalent in middle age (50–65) are independent predictors of adverse events
2021 · Lauriane Segaux, Amaury Broussier, et al. · Scientific Reports · 41
PDF
Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers
2025 · Vincent Bouteloup, Nicolas Villain, et al. · JAMA Neurology · 38
PDF
Practical Management of Frailty in Older Patients with Heart Failure
2022 · Anne-Sophie Boureau, Cédric Annweiler, et al. · ESC Heart Failure · 36
Quantitation of Alzheimer's amyloid peptide and identification of related amyloid proteins by dot-blot immunoassay
1995 · Bruno Permanne, Luc Buée, et al. · Brain Research · 22
Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes
2020 · Berivan Emsen, Gabriel Villafane, et al. · Medicine · 18
Identification of five frailty profiles in community-dwelling individuals aged 50–75: A latent class analysis of the SUCCEED survey data
2019 · Lauriane Segaux, Nadia Oubaya, et al. · Maturitas · 18
PDF
Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France
2023 · Thibaud Damy, Amira Zaroui, et al. · Archives of cardiovascular diseases · 16
White Matter Lesions: Prevalence and Clinical Phenotype in Asymptomatic Individuals Aged ≥50 Years
2016 · Jean-Philippe David, Emilie Ferrat, et al. · Dementia and Geriatric Cognitive Disorders · 13
Neuropsychiatric Symptoms in Elderly Inpatients: A Multicenter Cross-Sectional Study
2013 · A. Mézière, M. Blachier, et al. · Dementia and Geriatric Cognitive Disorders Extra · 13
Functional decline in geriatric rehabilitation ward; is it ascribable to hospital acquired infection? A prospective cohort study
2020 · Marie Laurent, Nadia Oubaya, et al. · BMC Geriatrics · 10
PDF
Works count: 55
Citation count: 2,566
H-index: 19
I10-index: 26
Year
Topic
Type